Physician profile
Kelsey A Risden
NPI 1689396178
$885.91
in general payments reported to CMS, 2019-2025
18 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $130 · 2024: $295 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $885.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $248.41 | 2024-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $156.51 | 2025 | |
| Novo Nordisk INC | $92.93 | 2024 | Ozempic, Rybelsus, Wegovy |
| Corium, LLC | $58.90 | 2023 | Azstarys |
| Ironshore Pharmaceuticals INC. | $57.77 | 2023 | Jornay Pm |
| Abbvie INC. | $47.61 | 2024-2025 | |
| Pfizer INC. | $28.44 | 2024 | |
| Scpharmaceuticals INC. | $23.62 | 2025 | |
| Janssen Pharmaceuticals, INC | $20.43 | 2024 | Spravato |
| Actelion Pharmaceuticals US, INC. | $19.79 | 2025 | Opsumit, Uptravi |
| Philips North America LLC | $18.81 | 2024 | (Ck7) Extended Holter |
| Heartflow, INC. | $17.99 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $17.56 | 2024 | Airsupra |
| Daxor Corporation | $16.91 | 2025 | Bva-100 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.64 | 2024 | Xifaxan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.62 | 2024 | Ofev |
| Phathom Pharmaceuticals, INC. | $14.31 | 2024 | Voquezna |
| Kyowa Kirin, INC. | $13.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Risden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.